| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.094 | 0.08 |